Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
6
×
national blog main
biotech
boston blog main
boston top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
ipo
pfizer
sanofi
startups
takeda pharmaceutical
alexion pharmaceuticals
amgen
boehringer ingelheim
bristol-myers squibb
What
bio
6
×
pharmaceutical
6
×
roundup
cancer
companies
drugs
hasn’t
latest
new
typically
alzheimer’s
american
appetite
approved
bails
based
best
bets
black
brand
bread
bridgebio
butter
buyout
capital
car
cash
combo
comes
continue
crash
cut
date
dating
deal
debate
develop
diabetes
diamond’s
different
Language
unset
Current search:
bio
×
pharmaceutical
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines